Nick Pavlakis, Sumitra Ananda, Howard Chan, Marion Harris, Warren Lance Joubert, Jin Won Kim, Choong-kun Lee, Woojin Lee, Lara Lipton, Adnan Nagrial, Do Youn Oh, Joon Oh Park, Terrie-Anne Cock, Sarah Kinkel, Nicole Kruger, Chris Burns, Jason Lickliter. "Narmafotinib (AMP945) in combination with gemcitabine and nab-paclitaxel as first-line treatment for patients with metastatic pancreatic cancer (ACCENT trial): Phase 2a results.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.735